The global Growth hormone Market size was valued at USD 4.6 billion in 2019 and is expected to record a CAGR of 8% over the forecast period. Factors such as investment from market participants, presence of strong pipelines, extensive R&D activities, strong product portfolio and growing government initiatives are expected to drive the market significantly.
A full report of Growth hormone Market available at https://www.orionmarketreports.com/growth-hormone-market/53742/
The prominent players in the market have adopted various strategies for increasing their market share. These include expansion of their regional presence through collaborations and partnerships and increase in investments to develop long-acting and effective products with lower adverse effects. Major players operating in the human growth hormone market include Novo Nordisk, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., Teva Pharmaceutical Industries Ltd, Novartis AG, AnkeBio Co. Ltd, F. Hoffmann-La Roche, Ipsen, and Ferring BV.
Growth hormone Market Segmentations
By Application
• Growth Hormone Deficiency
• Prader-Willi Syndrome
• Turner Syndrome
• Small for Gestational Age
• Others
By Route of Administration
• Intravenous
• Intramuscular
• Subcutaneous
• Oral
By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Clinics
• Online Pharmacy
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
